IE41138B1 - 16-methyl-9 -halo steroid ethers and esters and their preparation - Google Patents
16-methyl-9 -halo steroid ethers and esters and their preparationInfo
- Publication number
- IE41138B1 IE41138B1 IE2062/75A IE69275A IE41138B1 IE 41138 B1 IE41138 B1 IE 41138B1 IE 2062/75 A IE2062/75 A IE 2062/75A IE 69275 A IE69275 A IE 69275A IE 41138 B1 IE41138 B1 IE 41138B1
- Authority
- IE
- Ireland
- Prior art keywords
- tetrahydropyran
- acyloxy
- methyl
- preparation
- esters
- Prior art date
Links
- -1 -halo steroid ethers Chemical class 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000005886 esterification reaction Methods 0.000 abstract 2
- 239000004593 Epoxy Substances 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940051868 antimigraine drug corticosteroid derivative Drugs 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical class OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000741 silica gel Substances 0.000 abstract 1
- 229910002027 silica gel Inorganic materials 0.000 abstract 1
- 238000003797 solvolysis reaction Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT6163774 | 1974-03-27 | ||
| PT6163674 | 1974-03-27 | ||
| PT6163675 | 1975-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE41138B1 true IE41138B1 (en) | 1979-10-24 |
Family
ID=27354092
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2062/75A IE41138B1 (en) | 1974-03-27 | 1975-03-27 | 16-methyl-9 -halo steroid ethers and esters and their preparation |
| IE693/75A IE41137B1 (en) | 1974-03-27 | 1975-03-27 | 16-methyl-9 -halo steroid esters and ethers and preparation thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE693/75A IE41137B1 (en) | 1974-03-27 | 1975-03-27 | 16-methyl-9 -halo steroid esters and ethers and preparation thereof |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE827275A (enExample) |
| CH (2) | CH622811A5 (enExample) |
| DK (1) | DK153556C (enExample) |
| FR (1) | FR2274309A1 (enExample) |
| GB (2) | GB1511820A (enExample) |
| IE (2) | IE41138B1 (enExample) |
| NZ (1) | NZ177056A (enExample) |
| SE (1) | SE440656B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| IT1285770B1 (it) | 1996-10-04 | 1998-06-18 | Nicox Sa | Composti corticoidei |
| CN102516348B (zh) * | 2011-11-10 | 2013-11-13 | 中国科学院上海有机化学研究所 | 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1070751A (en) * | 1964-01-28 | 1967-06-01 | Glaxo Lab Ltd | 17-esters of 17-hydroxy-21-desoxy-steroids |
| GB1139505A (en) * | 1965-06-23 | 1969-01-08 | Glaxo Lab Ltd | A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids |
| CH481085A (de) * | 1965-08-30 | 1969-11-15 | Scherico Ltd | Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe |
| US3383394A (en) * | 1965-08-30 | 1968-05-14 | Schering Corp | Novel 17-acylating process and products thereof |
| BE788355A (fr) * | 1971-09-07 | 1973-03-05 | Merck Patent Gmbh | Esters de 9 alpha-fluoro-16-methylene-prednisolone |
-
1975
- 1975-03-26 NZ NZ177056A patent/NZ177056A/xx unknown
- 1975-03-26 GB GB47940/77A patent/GB1511820A/en not_active Expired
- 1975-03-26 GB GB12608/75A patent/GB1510617A/en not_active Expired
- 1975-03-26 CH CH392475A patent/CH622811A5/de not_active IP Right Cessation
- 1975-03-26 DK DK129575A patent/DK153556C/da not_active IP Right Cessation
- 1975-03-27 BE BE154849A patent/BE827275A/xx not_active IP Right Cessation
- 1975-03-27 IE IE2062/75A patent/IE41138B1/xx unknown
- 1975-03-27 IE IE693/75A patent/IE41137B1/xx unknown
- 1975-03-27 FR FR7509621A patent/FR2274309A1/fr active Granted
-
1978
- 1978-03-16 SE SE7803041A patent/SE440656B/sv not_active IP Right Cessation
-
1979
- 1979-10-22 CH CH946879A patent/CH625254A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE440656B (sv) | 1985-08-12 |
| DK153556C (da) | 1988-12-05 |
| GB1510617A (en) | 1978-05-10 |
| IE41137B1 (en) | 1979-10-24 |
| FR2274309A1 (fr) | 1976-01-09 |
| DK153556B (da) | 1988-07-25 |
| CH622811A5 (enExample) | 1981-04-30 |
| SE7803041L (sv) | 1978-03-16 |
| CH625254A5 (enExample) | 1981-09-15 |
| IE41137L (en) | 1975-09-27 |
| FR2274309B1 (enExample) | 1978-11-24 |
| NZ177056A (en) | 1978-09-20 |
| DK129575A (enExample) | 1975-09-28 |
| GB1511820A (en) | 1978-05-24 |
| BE827275A (fr) | 1975-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1475795A (en) | Steroid 21-thioesters | |
| CA1079725A (en) | Prostaglandin-acetylene analogues and process for their manufacture | |
| AU674980B2 (en) | Corticosteroid 17-alkyl carbonate 21-(O)-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds | |
| HU188067B (en) | Process for preparing delta 17/20/21-substituted steroids | |
| IE41137L (en) | 16-methyl -9ó- halo steroid esters and ethers. | |
| IE32938L (en) | 17alpha,21-orthocarbonates of steroid-derivatives and¹process for preparing them | |
| GB1363459A (en) | Pregnene 16,17-ketals | |
| GB1288414A (enExample) | ||
| IE800050L (en) | 21-alkylated steroids | |
| IE43305L (en) | Steroidal naphthalenes | |
| IE36592B1 (en) | Process for the manufacture of pregnane derivatives | |
| GB1145336A (en) | 17--[3' furyl]-estrogens and process for the preparation thereof | |
| IE32868B1 (en) | Halogenated steroids and process for the manufacture thereof | |
| IE37657L (en) | Prednisolone derivative. | |
| GB1450807A (en) | Cardenolide glycosides and process for their manufacture | |
| IE42468L (en) | 13-ethynyl- and 13-(2 halovinyl)-steroids | |
| US2923722A (en) | 2-lower-alkyl-9alpha-halo-4-pregnenes | |
| GB1311725A (en) | 18-cyano pregnane compounds and process for their manufacture | |
| GB1503805A (en) | Halo-steroidal thioketals | |
| DD233997A5 (de) | Verfahren zur herstellung von carbacyclinen | |
| GB1291293A (en) | Steroid carbonates and their preparation | |
| GB1242372A (en) | A new oestratriol and a process for its manufacture | |
| Jones et al. | A new approach to the introduction of corticoid-like C-17 functions via 2-lithio-1, 3-dithian–epoxide reactions | |
| GB1502513A (en) | Steroid(16,17-b)dioxanes | |
| GB1087730A (en) | Novel steroid-21-esters, processes for their preparation, and pharmaceutical compositions containing them |